U.S. private equity firms have expanded into the global market for lead chromate, a chemical tied to lead poisoning and cancer, raising alarms among health experts over its continued use in poorer nations.
Will Fitzgibbon reports for The Examination.
In short:
- Blackstone and American Securities LLC acquired firms that distribute lead chromate, despite its known health risks and restrictions in wealthier countries.
- Lead chromate is used in paints and industrial applications in many developing nations, where regulations are less stringent or nonexistent.
- Health experts are concerned about the long-term effects of lead exposure from these products, particularly on children.
Key quote:
“There is definitely an opportunity to sell more lead chromate pigments in developing countries where they would be needed.... There generally are fewer regulations in these regions regarding what types of pigments can be used."
David Wawer, executive director of the U.S. pigment lobby group
Why this matters:
Lead exposure is a serious public health issue, especially in developing nations. With private equity firms fueling its production, global health risks could rise, especially in vulnerable communities where regulations lag behind. Read more: Tracking down a poison: Getting the lead out of spices in Bangladesh and Georgia.
